EVALUATION OF THE EFFICACY OF SWITCHING FROM ORIGINATOR ADALIMUMAB TO BIOSIMILAR ADALIMUMAB-AACF IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS: A 12-MONTHS OBSERVATIONAL STUDY
Congresso Brasileiro de Reumatologia(2024)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined